Pruritus in primary biliary cholangitis is under-recorded in patient medical records

被引:3
|
作者
Gungabissoon, Usha [1 ]
Smith, Helen T. [1 ]
von Maltzahn, Robyn [1 ]
Logie, John [1 ]
Fairburn-Beech, Jolyon [1 ]
Ma, Liyuan [2 ]
Dhirishiya, P. [3 ]
McGirr, Ashleigh [4 ]
Hunnicutt, Jake N. [2 ]
Rowe, Christopher L. [5 ]
Tierney, Meghan [5 ]
Friedler, Haley S. [5 ]
机构
[1] GSK, London, England
[2] GSK, Collegeville, PA USA
[3] GSK, Bangalore, India
[4] GSK, Mississauga, ON, Canada
[5] PicnicHlth, San Francisco, CA USA
来源
BMJ OPEN GASTROENTEROLOGY | 2024年 / 11卷 / 01期
关键词
QUALITY OF LIFE; CHOLESTATIC LIVER DISEASES; CHOLESTASIS; HEPATOBILIARY DISEASE; EPIDEMIOLOGY; QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; MANAGEMENT; BEZAFIBRATE; CIRRHOSIS;
D O I
10.1136/bmjgast-2023-001287
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Cholestatic pruritus in primary biliary cholangitis (PBC) reduces patients' health-related quality of life (HRQoL). Despite this, existing research suggests that pruritus is under-recorded in patients' health records. This study assessed the extent to which pruritus was recorded in medical records of patients with PBC as compared with patient-reported pruritus, and whether patients reporting mild itch were less likely to have pruritus recorded. We also evaluated clinico-demographic characteristics and HRQoL of patients with medical record-documented and patient-reported pruritus.Design This cross-sectional study used clinical information abstracted from medical records, together with patient-reported (PBC-40) data from patients with PBC in the USA enrolled in the PicnicHealth cohort. Medical record-documented pruritus was classified as 'recent' (at, or within 12 months prior to, enrolment) or 'ever' (at, or any point prior to, enrolment). Patient-reported pruritus (4-week recall) was assessed using the first PBC-40 questionnaire completed on/after enrolment; pruritus severity was classified by itch domain score (any severity: >= 1; clinically significant itch: >= 7). Patient clinico-demographic characteristics and PBC-40 domain scores were described in patients with medical record-documented and patient-reported pruritus; overlap between groups was evaluated. Descriptive statistics were reported.Results Pruritus of any severity was self-reported by 200/225 (88.9%) patients enrolled; however, only 88/225 (39.1%) had recent medical record-documented pruritus. Clinically significant pruritus was self-reported by 120/225 (53.3%) patients; of these, 64/120 (53.3%) had recent medical record-documented pruritus. Patients reporting clinically significant pruritus appeared to have higher mean scores across PBC-40 domains (indicating reduced HRQoL), versus patients with no/mild patient-reported pruritus or medical-record documented pruritus.Conclusion Compared with patient-reported measures, pruritus in PBC is under-recorded in medical records and is associated with lower HRQoL. Research based only on medical records underestimates the true burden of pruritus, meaning physicians may be unaware of the extent and impact of pruritus, leading to potential undertreatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Understanding and Treating Pruritus in Primary Biliary Cholangitis
    Carrion, Andres F.
    Rosen, Jordan D.
    Levy, Cynthia
    CLINICS IN LIVER DISEASE, 2018, 22 (03) : 517 - +
  • [2] Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis
    Shah, Raj A.
    Kowdley, Kris, V
    SEMINARS IN LIVER DISEASE, 2019, 39 (02) : 209 - 220
  • [3] Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC)
    Sun, Ying
    Zhang, Weici
    Evans, Jilly F.
    Floreani, Annarosa
    Zou, Zhengsheng
    Nishio, Yukiko
    Qi, Ruizhao
    Leung, Patrick S. C.
    Bowlus, Christopher L.
    Gershwin, M. Eric
    AUTOIMMUNITY REVIEWS, 2016, 15 (08) : 795 - 800
  • [4] Evaluation and Management of Pruritus in Primary Biliary Cholangitis
    Dull, Miriam M.
    Kremer, Andreas E.
    CLINICS IN LIVER DISEASE, 2022, 26 (04) : 727 - 745
  • [5] The Devastating Impact of Severe Pruritus in Primary Biliary Cholangitis
    Smith, Helen T.
    McLaughlin, Megan M.
    Das, Sugato
    Ribeiro, Andrea
    Troke, Philip J. F.
    Kremer, Andreas
    Jones, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S85 - S86
  • [6] The devastating impact of severe pruritus in primary biliary cholangitis
    Smith, H. T.
    Mclaughlin, M. M.
    Das, S.
    Ribeiro, A.
    Andreone, P.
    Troke, P. jf
    Kremer, A. E.
    Jones, D.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [7] UNDERSTANDING THE EXPERIENCE OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND PRURITUS
    Levy, C.
    Williams, B.
    Sowell, F.
    Serafini, P.
    Giao, Antunes N. T.
    Zein, C.
    Dietrich, J.
    Addy, C.
    Vargas, D.
    Schattenberg, J. M.
    VALUE IN HEALTH, 2023, 26 (06) : S318 - S318
  • [8] Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review
    Trivedi, Hirsh D.
    Lizaola, Blanca
    Tapper, Elliot B.
    Bonder, Alan
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06): : 744.e1 - 744.e7
  • [9] The devastating impact of severe pruritus in primary biliary cholangitis
    Smith, Helen
    McLaughlin, Megan
    Das, Sugato
    Ribeiro, Andrea
    Troke, Philip
    Kremer, Andreas E.
    Jones, David
    JOURNAL OF HEPATOLOGY, 2023, 78 : S397 - S398
  • [10] IDENTIFYING DRIVERS OF PATIENT (PT) PREFERENCE IN THE TREATMENT OF PRURITUS IN PRIMARY BILIARY CHOLANGITIS (PBC)
    Halliday, Anna
    Smith, Helen T.
    Szinay, Dorothy
    Walker, Andy
    Meginnis, Keila
    Heidenreich, Sebastian
    Seo, Jaein
    HEPATOLOGY, 2023, 78 : S2051 - S2052